Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals

Front Immunol. 2022 Jan 6:12:793142. doi: 10.3389/fimmu.2021.793142. eCollection 2021.

Abstract

SARS-CoV-2 has infected more than 200 million people worldwide, with more than 4 million associated deaths. Although more than 80% of infected people develop asymptomatic or mild COVID-19, SARS-CoV-2 can induce a profound dysregulation of the immune system. Therefore, it is important to investigate whether clinically recovered individuals present immune sequelae. The potential presence of a long-term dysregulation of the immune system could constitute a risk factor for re-infection and the development of other pathologies. Here, we performed a deep analysis of the immune system in 35 COVID-19 recovered individuals previously infected with SARS-CoV-2 compared to 16 healthy donors, by flow cytometry. Samples from COVID-19 individuals were analysed from 12 days to 305 days post-infection. We observed that, 10 months post-infection, recovered COVID-19 patients presented alterations in the values of some T-cell, B-cell, and innate cell subsets compared to healthy controls. Moreover, we found in recovered COVID-19 individuals increased levels of circulating follicular helper type 1 (cTfh1), plasmablast/plasma cells, and follicular dendritic cells (foDC), which could indicate that the Tfh-B-foDC axis might be functional to produce specific immunoglobulins 10 months post-infection. The presence of this axis and the immune system alterations could constitute prognosis markers and could play an important role in potential re-infection or the presence of long-term symptoms in some individuals.

Keywords: COVID-19; flow cytometry; immune dysregulation; immune system; unsupervised algorithms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • COVID-19 / blood
  • COVID-19 / immunology*
  • COVID-19 / virology
  • Case-Control Studies
  • Cohort Studies
  • Convalescence*
  • Dendritic Cells, Follicular / immunology*
  • Female
  • Flow Cytometry / methods*
  • Health Personnel*
  • Humans
  • Lymphocyte Activation / immunology*
  • Male
  • Middle Aged
  • Plasma Cells / immunology*
  • Polymerase Chain Reaction / methods
  • Prognosis
  • SARS-CoV-2 / genetics*
  • T Follicular Helper Cells / immunology*
  • Young Adult

Substances

  • Antibodies, Viral